References
- Meininger V. Clinical trials: the past, a lesson for the future. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2(Suppl): S15–S18.
- Merriam-Websters Online Collegiate Thesaurus 2001: http://www.m-w.com/dictionary.htm
- European College of Neuropsychopharmacology. Note for guidance: clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (ALS). Eur Neu- ropsychopharmacol 2001; 11: 187–189
- Bradley WG, Bowen BC, Pattany PM, Rotta F. Related Arti- cles 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 84–86.
- Lesko LJ, Atkinson AJ Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001; 41: 347–366.
- Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996; 125: 605–613.
- Felice KJ, North WA. Creatine kinase values in amyotrophic lateral sclerosis. J Neurol Sci 1998; 160(Suppl): S30–S32.
- Bonnefont-Rousselot D, Lacomblez L, Jaudon M, Lepage S, Salachas F, Bensimon G, Bizard C, Doppler V, Delattre J, Meininger V. Blood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci 2000; 178: 57–62.
- Gooch CL, Harati Y. Motor unit number estimation, ALS and clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 71–82.
- Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998; 51: 1104–1109.
- Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N- acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998; 9: 1757–1761.
- Pohl C, Block W, Traber F et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001; 190: 21–17.
- Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50: 1800–1805.